IDEAYA Biosciences (IDYA) Return on Sales (2020 - 2026)

IDEAYA Biosciences (IDYA) has 7 years of Return on Sales data on file, last reported at 0.35% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed N/A year-over-year to 0.35%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (changed N/A YoY), and the FY2025 full-year result was 0.02%, up 69.0% from the prior year.
• Return on Sales declined to 0.35% in Q1 2026, from 0.09% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.99% in Q3 2024.
• A 5-year average of 0.16% and a median of 0.09% in 2025 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales tumbled 95 bps in 2024 and soared 99 bps in 2025, its largest moves.
• Tracing IDYA's Return on Sales over 5 years: stood at 0.06% in 2022, then slumped by 59 bps to 0.1% in 2023, then sank by 111 bps to 0.21% in 2024, then surged by 59 bps to 0.09% in 2025, then slumped by 309 bps to 0.35% in 2026.
• Business Quant data shows IDYA's Return on Sales at 0.35% in Q1 2026, 0.09% in Q4 2025, and 0.0% in Q3 2025.